ArticlePloS one2014

Tumor vasculature-targeted recombinant mutated human TNF-α enhanced the antitumor activity of doxorubicin by increasing tumor vessel permeability in mouse xenograft models.

Changli Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.